Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

@inproceedings{Chen2015BaselineAT,
  title={Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors},
  author={Yu-Mu Chen and Chien-Hao Lai and Huang-Chih Chang and Tung-Ying Chao and Chia-Cheng Tseng and Wen-Feng Fang and Chin-Chou Wang and Y H Chung and Yi-Hsi Wang and Mao-Chang Su and Kuo-Tung Huang and Hung-Chen Chen and Ya-Chun Chang and Meng-Chih Lin and Armin Gerger},
  booktitle={PloS one},
  year={2015}
}
BACKGROUND Patients with early-stage lung cancer who have a high baseline lymphocyte-to-monocyte ratio (LMR) have a favorable prognosis. However, the prognostic significance of LMR in patients with advanced-stage EGFR-mutant non-small cell lung cancer (NSCLC) receiving first-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) has not been established. We conducted a retrospective analysis to investigate the influence of LMR on clinical outcomes including progression… CONTINUE READING
Highly Cited
This paper has 24 citations. REVIEW CITATIONS
16 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…